Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study

The efficacy of pure and aluminum (Al)-doped boron nitride nanocarriers (B<sub>12</sub>N<sub>12</sub> and AlB<sub>11</sub>N<sub>12</sub>) in adsorbing Chlormethine (CM), an anti-cancer drug, was comparatively dissected by means of the density functiona...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahmoud A. A. Ibrahim (Author), Al-shimaa S. M. Rady (Author), Asmaa M. A. Mandarawe (Author), Lamiaa A. Mohamed (Author), Ahmed M. Shawky (Author), Tamer H. A. Hasanin (Author), Peter A. Sidhom (Author), Mahmoud E. S. Soliman (Author), Nayra A. M. Moussa (Author)
Format: Book
Published: MDPI AG, 2022-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1d8ea5ac4e664b908d025f1b6ac08a7d
042 |a dc 
100 1 0 |a Mahmoud A. A. Ibrahim  |e author 
700 1 0 |a Al-shimaa S. M. Rady  |e author 
700 1 0 |a Asmaa M. A. Mandarawe  |e author 
700 1 0 |a Lamiaa A. Mohamed  |e author 
700 1 0 |a Ahmed M. Shawky  |e author 
700 1 0 |a Tamer H. A. Hasanin  |e author 
700 1 0 |a Peter A. Sidhom  |e author 
700 1 0 |a Mahmoud E. S. Soliman  |e author 
700 1 0 |a Nayra A. M. Moussa  |e author 
245 0 0 |a Adsorption of Chlormethine Anti-Cancer Drug on Pure and Aluminum-Doped Boron Nitride Nanocarriers: A Comparative DFT Study 
260 |b MDPI AG,   |c 2022-09-01T00:00:00Z. 
500 |a 10.3390/ph15101181 
500 |a 1424-8247 
520 |a The efficacy of pure and aluminum (Al)-doped boron nitride nanocarriers (B<sub>12</sub>N<sub>12</sub> and AlB<sub>11</sub>N<sub>12</sub>) in adsorbing Chlormethine (CM), an anti-cancer drug, was comparatively dissected by means of the density functional theory method. The CM∙∙∙B<sub>12</sub>N<sub>12</sub> and ∙∙∙AlB<sub>11</sub>N<sub>12</sub> complexes were studied within two configurations, A and B, in which the adsorption process occurred via N∙∙∙ and Cl∙∙∙B/Al interactions, respectively. The electrostatic potential affirmations confirmed the opulent ability of the studied nanocarriers to engage in delivering CM via two prominent electrophilic sites (B and Al). Furthermore, the adsorption process within the CM∙∙∙AlB<sub>11</sub>N<sub>12</sub> complexes was noticed to be more favorable compared to that within the CM∙∙∙B<sub>12</sub>N<sub>12</sub> analog and showed interaction and adsorption energy values up to -59.68 and −52.40 kcal/mol, respectively, for configuration A. Symmetry-adapted perturbation theory results indicated that electrostatic forces were dominant in the adsorption process. Notably, the adsorption of CM over B<sub>12</sub>N<sub>12</sub> and AlB<sub>11</sub>N<sub>12</sub> nanocarriers exhibited predominant changes in their electronic properties. An elemental alteration was also revealed for the softness and hardness of B<sub>12</sub>N<sub>12</sub> and AlB<sub>11</sub>N<sub>12</sub> nanocarriers before and following the CM adsorption. Spontaneity and exothermic nature were obviously observed for the studied complexes and confirmed by the negative values of thermodynamic parameters. In line with energetic manifestation, Gibbs free energy and enthalpy change were drastically increased by the Al doping process, with values raised to -37.15 and -50.14 kcal/mol, respectively, for configuration A of the CM∙∙∙AlB<sub>11</sub>N<sub>12</sub> complex. Conspicuous enhancement was noticed for the adsorption process in the water phase more than that in the gas phase and confirmed by the negative values of the solvation energy up to −53.50 kcal/mol for configuration A of the CM∙∙∙AlB<sub>11</sub>N<sub>12</sub> complex. The obtained outcomes would be the linchpin for the future utilization of boron nitride as a nanocarrier. 
546 |a EN 
690 |a boron nitride nanocarriers 
690 |a Chlormethine 
690 |a anti-cancer drug 
690 |a DFT calculations 
690 |a thermodynamic parameters 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 15, Iss 10, p 1181 (2022) 
787 0 |n https://www.mdpi.com/1424-8247/15/10/1181 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/1d8ea5ac4e664b908d025f1b6ac08a7d  |z Connect to this object online.